Kerri Langer
Psychiatry · Aurora, CONPI 1184943920
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.4% of the total across 239 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 23.0% — the pattern of someone who eats at a lot of different presentations. Among psychiatry clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 239 payments — averaging $18.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Neurocrine Biosciences, Inc.$499
- Lundbeck LLC$472
- Otsuka America Pharmaceutical, Inc.$391
- Teva Pharmaceuticals USA, Inc.$332
- Alkermes, Inc.$307
- plus $1K from 16 others
What the payments were for
- Food & beverage$4,37698%
- Education$712%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 72 | $1,022 |
| Neurocrine Biosciences, Inc. | 20 | $499 |
| Lundbeck LLC | 24 | $472 |
| Otsuka America Pharmaceutical, Inc. | 20 | $391 |
| Teva Pharmaceuticals USA, Inc. | 16 | $332 |
| Alkermes, Inc. | 13 | $307 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $262 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $239 |
| Sunovion Pharmaceuticals Inc. | 15 | $202 |
| Vanda Pharmaceuticals Inc. | 5 | $124 |
| Bausch Health US, LLC | 5 | $104 |
| Avanir Pharmaceuticals, Inc. | 6 | $99 |
| Idorsia Pharmaceuticals US Inc | 4 | $69 |
| Adlon Therapeutics L.p. | 3 | $55 |
| Corium, LLC | 3 | $54 |
| Neos Therapeutics, LP | 3 | $53 |
| Johnson & Johnson | 2 | $46 |
| Shire North American Group Inc | 2 | $42 |
| Merck | 1 | $24 |
| Neuronetics, Inc. | 1 | $20 |
| Alfasigma USA, Inc. | 1 | $20 |
| Eisai Inc. | 1 | $11 |
How this compares
$4,448 in reported general payments places this provider in the 90th percentile of 559 psychiatry providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clonazepam | 33 | $509 |
| Lamotrigine | 11 | $454 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Aurora
- Cynthia EppersonAurora$64K
- Eric FrenchAurora$10K
- Rachel DavisAurora$6K
- Xuan KangAurora$5K
- Andrew NovickAurora$3K
- Michael AllenAurora$2K
- John HardyPueblo$828K
- Larry SandersLittleton$760K
- Jeffrey RichmondDenver$424K
- Jennifer FrenchGlendale$115K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.